Respiratory

#educate_the_vape
Respiratory

#Educate_the_Vape: Standing Tall to Help Teens Quit

By Rachel Clevenger, RRT, ECG, CTP The snowballing effect of digital publicity has placed vaping and e-cigarette related lung injuries at the pinnacle of every modern medical conversation for the last several weeks. There are floating questions about a push for state legislation of the products, discussions about CEOs stepping […]

cystic fibrosis lungs
Respiratory

CF Patients Experience Improved Lung Health with Lumacaftor-Ivacaftor But with Caveats

In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI®), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. However, […]

vaping liquid
Respiratory

Vaping and Acute Lung Injuries

By Rachel Clevenger, RRT, ECG, CTP For the last few weeks of September, it would appear that every other post on social media or breaking news story is about another case of severe lung infection or fatality tied vaping or e-cigarettes use. This tragedy of over 300 teens and adults […]

HIPSTER VAPING
Respiratory

“No Vape” Statement From AMA

AMA urges public to avoid e-cigarette use amid lung illness outbreak “In light of increasing reports of e-cigarette-associated lung illnesses across the country, the AMA urges the public to avoid the use of e-cigarette products until health officials further investigate and understand the cause of these illnesses. The AMA recommends […]

banned
Respiratory

Michigan Governor Bans All Flavored Vaping Products

The American Thoracic Society applauds Michigan Governor Gretchen Whitmer’s decision to ban the sale of all flavored e-cigarette and vaping products in the state of Michigan. Governor Whitmer’s decision is an appropriate response to the 215 recently reported cases of e-cigarette triggered acute illnesses that have resulted in hospitalization and in at […]

woman with lung pain
Respiratory

Ivacaftor May Reduce Common Infections in Patients with CF

Patients with cystic fibrosis who take ivacaftor appear to have fewer respiratory infections over time than those not taking the drug, according to new research published online in the Annals of the American Thoracic Society. Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Ivacaftor […]